HSD17B13 and Hepatic fibrosis: indicated that the protection against hepatic fibrosis induced by the human HSD17B13 variant and the mouse HSD17B13 KO was associated with reduced pyrimidine catabolism at the level of dihydropyrimidine dehydrogenase.